X

Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

Johnson & Johnson, Pfizer, Walgreens and other CEOs discuss value in the future of health care

By Holly Campbell  |    September 21, 2017
As part of The Value Collaborative, an initiative of America’s biopharmaceutical companies, we recently hosted an event with Bloomberg about unlocking and supporting value in the future of health...   Read More

More than 85 medicines in development for Alzheimer’s disease

By Andrew Powaleny  |    September 21, 2017
When Brian Kursonis started “blanking out” for moments at a time, a scan revealed plaques of a protein called amyloid in the brain, one sign of Alzheimer’s disease. A test of his spinal fluid...   Read More

The journey to better health care requires a holistic view

By Guest Contributor  |    September 18, 2017
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...   Read More

What they are saying: Study on cancer R&D costs is not an accurate representation of marketplace

By Holly Campbell  |    September 12, 2017
A recent study published in JAMA Internal Medicine provides flawed and inaccurate estimates of the significant research and development (R&D) investments made by biopharmaceutical companies to...   Read More

Medicare Monday: Medicare Part D by the numbers

By Nicole Longo  |    September 11, 2017
Getting back into the swing of things as Fall approaches? Here’s some light Medicare reading! And if you need a refresher, you can go back to our ABC (and Ds) of Medicare post:   Read More

Working to harness the power of the body’s own immune system

By Guest Contributor  |    September 7, 2017
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...   Read More

How biopharmaceutical collaboration is driving a new era of medicine

By Andrew Powaleny  |    September 7, 2017
Biopharmaceutical innovation, coupled with technological advancements, has brought a new era of medicine transforming how we research and develop new medicines to benefit patients.   Read More

Protect your health: Important disaster preparedness tips for Harvey and Irma

By Guest Contributor  |    September 6, 2017
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...   Read More

Helping those affected by Hurricanes Harvey and Irma

By Holly Campbell  |    August 31, 2017
This post has been updated as of 9/18/2017 to reflect relief efforts related to both Hurricane Harvey and Hurricane Irma. Given the unprecedented scale of the devastation and flooding caused by...   Read More

SB 17 doesn’t address pressing prescription drug transparency issues for CA voters

By Priscilla VanderVeer  |    August 30, 2017
California’s SB 17 is one of a number of bills relating to prescription drug transparency around prescription medicine costs that are winding their way through U.S. statehouses.   Read More

Search the Catalyst

View Posts by Topic

see all

Subscribe to Email Updates